Literature DB >> 9341125

UDP-glucuronosyltransferase, the role of the amino terminus in dimerization.

R Meech1, P I Mackenzie.   

Abstract

UDP-glucuronosyltransferases (UGTs) comprise an important enzyme system in mammals that is involved in detoxification of a variety of small hydrophobic compounds of both endogenous and exogenous origin. Some evidence suggests that these enzymes may function as oligomers; however, little is known about the domain of interaction or the mechanism of oligomerization. In this work, evidence for a functional dimerization between UGTs is provided by studies on mutated forms of UGT2B1. When two inactive forms of UGT2B1 were co-expressed in cell culture, catalytic activity was restored, indicating that UGT2B1 forms functional dimers. To delineate the dimerization domain, inactive fusion proteins containing the amino- or carboxyl-terminal domains of UGT2B1 were generated and expressed with active UGT2B1. Expression of a fusion protein containing only the amino-terminal half of UGT2B1 with active UGT2B1 caused a reduction in UGT2B1 catalytic activity. This reduction in activity was not observed when UGT2B1 was co-expressed with a fusion protein containing only the carboxyl-terminal half of UGT2B1, strongly suggesting that the amino-terminal domain is involved in dimerization. Truncation of the immediate amino terminus of UGT2B1 abolished UGT2B1 activity and dimer formation. Activity was also abolished by an L4R substitution in this region of the mature protein, which is highly conserved in the UGT family. These results indicate that UGTs can interact through their amino-terminal domains to form catalytically active dimers. Possible mechanisms resulting in the formation and stabilization of the UGT2B1 dimer are discussed.

Mesh:

Substances:

Year:  1997        PMID: 9341125     DOI: 10.1074/jbc.272.43.26913

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.

Authors:  Judith Bellemare; Mélanie Rouleau; Mario Harvey; Chantal Guillemette
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

2.  Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).

Authors:  Jin Zhou; Upendra A Argikar; John O Miners
Journal:  Methods Mol Biol       Date:  2021

3.  Absolute quantification of UGT1A1 in various tissues and cell lines using isotope label-free UPLC-MS/MS method determines its turnover number and correlates with its glucuronidation activities.

Authors:  Beibei Xu; Song Gao; Baojian Wu; Taijun Yin; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2013-08-29       Impact factor: 3.935

4.  Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family.

Authors:  Tsutomu Kobayashi; Judith E Sleeman; Michael W H Coughtrie; Brian Burchell
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

5.  Cloning and comparative analyses of the zebrafish Ugt repertoire reveal its evolutionary diversity.

Authors:  Haiyan Huang; Qiang Wu
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

Review 6.  A systems biology perspective on Nrf2-mediated antioxidant response.

Authors:  Qiang Zhang; Jingbo Pi; Courtney G Woods; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

7.  Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.

Authors:  Federico Innocenti; Wanqing Liu; Donna Fackenthal; Jacqueline Ramírez; Peixian Chen; Xin Ye; Xiaolin Wu; Wei Zhang; Snezana Mirkov; Soma Das; Edwin Cook; Mark J Ratain
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

8.  Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes.

Authors:  Camille M Konopnicki; Leslie J Dickmann; Jeffrey M Tracy; Robert H Tukey; Larry C Wienkers; Robert S Foti
Journal:  Arch Biochem Biophys       Date:  2013-04-04       Impact factor: 4.013

9.  Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.

Authors:  Michael J Miley; Agnieszka K Zielinska; Jeffrey E Keenan; Stacie M Bratton; Anna Radominska-Pandya; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

10.  UDP-glucuronosyltransferase 1a enzymes are present and active in the mouse blastocyst.

Authors:  Abby C Collier; Yasuhiro Yamauchi; Brittany L M Sato; Luc R A Rougée; Monika A Ward
Journal:  Drug Metab Dispos       Date:  2014-09-08       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.